A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice

Overview of attention for article published in Journal of Translational Medicine, February 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 1 X user
patent: 3 patents

facebook: 1 Facebook page

Readers on

mendeley: 52 Mendeley

Summary X Patents Facebook

So far, Altmetric has seen 3 patents that reference this research output.

Virus-like particle compositions and vaccines against epstein-barr virus infection and…

Grant US-10960072-B2

United States of America

EPSTEIN-BARR VIRUS-LIKE PARTICLES WITH BROADENED ANTIGENIC SPECTRUM

Application WO-2020074708-A1

World Intellectual Property Organisation (WIPO)

Virus-like particle compositions and vaccines against Epstein-Barr virus infection and…

Grant US-10314906-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.